Skip to main content
$8.51 -$0.11 (-1.3%)

04:00 PM EDT on 10/21/21

Co-Diagnostics, Inc. (NASDAQ:CODX)

CAPS Rating: 1 out of 5

Current Price $8.51 Mkt Cap $245.9M
Open $8.58 P/E Ratio 5.04
Prev. Close $8.51 Div. (Yield) $0.00 (0.0%)
Daily Range $8.40 - $8.70 Volume 1,882
52-Wk Range $7.01 - $20.69 Avg. Daily Vol. 453,497

Caps

How do you think NASDAQ:CODX will perform against the market?

Add Stock to CAPS Watchlist

All Players

35 Outperform
36 Underperform
 

All-Star Players

8 Outperform
20 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CODX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

peacemaker01 (67.06)
Submitted April 19, 2020

CODX is a frontrunner in diagnostic tests for covid19.

joaquingrech (96.83)
Submitted March 27, 2020

it may surge now but long term i just don't see it, only 1 product and easy to replicate

NASDAQ:CODX VS S&P 500 (SPY)

NASDAQ:CODX Summary

Fools bullish on NASDAQ:CODX are also bullish on:

Fools bearish on NASDAQ:CODX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CODX.

Recs

0
Member Avatar BuyouTech (< 20) Submitted: 5/13/2021 5:42:16 PM : Outperform Start Price: $7.49 NASDAQ:CODX Score: +9.60

Tiny $200M market cap biotech that is already profitable. No debt and 50% margins. Has patented co-primer technology that works with both DNA and RNA. Approx. 50% International sales of Covid 19 PCR test. Pursuing a broad range of clinical testing possibilities including liquid biopsy cancer detection and direct to consumer Covid testing.

Recs

0
Member Avatar Kentuckyfarmer (61.47) Submitted: 1/15/2021 7:22:08 AM : Outperform Start Price: $10.13 NASDAQ:CODX Score: -36.42

Increased revenue in 2020 was due to covid-19 testing and that was just what the company needed to finally become profitable. They have many other test capabilities if Covid-19 tests go away. They are also involved in the agricultural field which is another interesting avenue for growth in the future. Small cap with lots of room to run

Recs

0
Member Avatar TMFbonefish (62.99) Submitted: 1/12/2021 7:09:04 PM : Outperform Start Price: $10.42 NASDAQ:CODX Score: -38.12

Intellectual property that results in better product performance in a fast-growing competitive space is a recipe for getting acquired or being in a position to take share from others. Applications in agriculture are also intriguing.

Leaderboard

Find the members with the highest scoring picks in CODX.

Score Leader

copetom

copetom (37.60) Score: +426.68

Due to the panic over covid-19 I marked it as outperform. Which it did for a few days. I have since sold it, NVAX, INO, and 2 others. Nice profit on NVAX especially.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
OklaBoston 64.40 1/29/2020 Outperform 3Y $2.34 +263.68% +38.44% +225.24 2 Comments
Toprope101 99.43 3/12/2020 Underperform 5Y $12.76 -33.31% +77.22% +110.53 0 Comment
Halffrenzy 25.59 5/20/2020 Underperform 5Y $18.43 -53.83% +52.36% +106.19 0 Comment
NorteClub 34.83 7/29/2020 Underperform 5Y $22.14 -61.56% +40.85% +102.41 0 Comment
RayNobleEsq 99.94 4/21/2020 Underperform 5Y $13.46 -36.78% +65.07% +101.84 0 Comment
dinasourneil 98.84 3/6/2020 Underperform 1Y $14.23 -40.20% +54.85% +95.05 0 Comment
ClientNein 99.03 7/17/2020 Underperform 5Y $17.75 -52.06% +40.96% +93.02 0 Comment
chrispycrunch 86.53 3/5/2020 Underperform 5Y $14.65 -41.91% +48.93% +90.84 0 Comment
cvdynasty0 99.77 4/16/2020 Underperform 5Y $11.28 -24.56% +63.62% +88.18 0 Comment
jackbot 95.00 6/5/2020 Underperform 5Y $15.83 -46.24% +41.47% +87.71 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CODX.